OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
24
Results
Show all
Save search
Copy query
Show results for
Unknown
(24)
Publication Date
Release Date
2021
(4)
2024
(3)
2020
(3)
2026
(2)
2025
(2)
2019
(2)
2018
(2)
2023
(1)
2022
(1)
2013
(1)
2012
(1)
2011
(1)
2009
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Bone microarchitecture assessed by High-resolution peripheral quantitative computed tomography in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study.
Not available
S-EPMC12607258
|
biostudies-literature
Cite
Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04).
Not available
S-EPMC6303395
|
biostudies-literature
Cite
The Global Kidney Patient Trials Network and the CAPTIVATE Platform Clinical Trial Design: A Trial Protocol.
Not available
S-EPMC11635535
|
biostudies-literature
Cite
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
Not available
S-EPMC5840256
|
biostudies-literature
Cite
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.
Not available
S-EPMC6722042
|
biostudies-literature
Cite
Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data.
Not available
S-EPMC6647051
|
biostudies-literature
Cite
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Not available
S-EPMC3596060
|
biostudies-literature
Cite
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.
Not available
S-EPMC6974400
|
biostudies-literature
Cite
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.
Not available
S-EPMC2921823
|
biostudies-literature
Cite
The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause.
Not available
S-EPMC4802157
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets